BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 22887833)

  • 1. Growth standards of patients with Noonan and Noonan-like syndromes with mutations in the RAS/MAPK pathway.
    Malaquias AC; Brasil AS; Pereira AC; Arnhold IJ; Mendonca BB; Bertola DR; Jorge AA
    Am J Med Genet A; 2012 Nov; 158A(11):2700-6. PubMed ID: 22887833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum.
    Sarkozy A; Carta C; Moretti S; Zampino G; Digilio MC; Pantaleoni F; Scioletti AP; Esposito G; Cordeddu V; Lepri F; Petrangeli V; Dentici ML; Mancini GM; Selicorni A; Rossi C; Mazzanti L; Marino B; Ferrero GB; Silengo MC; Memo L; Stanzial F; Faravelli F; Stuppia L; Puxeddu E; Gelb BD; Dallapiccola B; Tartaglia M
    Hum Mutat; 2009 Apr; 30(4):695-702. PubMed ID: 19206169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The face of Noonan syndrome: Does phenotype predict genotype.
    Allanson JE; Bohring A; Dörr HG; Dufke A; Gillessen-Kaesbach G; Horn D; König R; Kratz CP; Kutsche K; Pauli S; Raskin S; Rauch A; Turner A; Wieczorek D; Zenker M
    Am J Med Genet A; 2010 Aug; 152A(8):1960-6. PubMed ID: 20602484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOS1 is the second most common Noonan gene but plays no major role in cardio-facio-cutaneous syndrome.
    Zenker M; Horn D; Wieczorek D; Allanson J; Pauli S; van der Burgt I; Doerr HG; Gaspar H; Hofbeck M; Gillessen-Kaesbach G; Koch A; Meinecke P; Mundlos S; Nowka A; Rauch A; Reif S; von Schnakenburg C; Seidel H; Wehner LE; Zweier C; Bauhuber S; Matejas V; Kratz CP; Thomas C; Kutsche K
    J Med Genet; 2007 Oct; 44(10):651-6. PubMed ID: 17586837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the SHOC2-MRAS-PP1C complex provides insights into RAF activation and Noonan syndrome.
    Bonsor DA; Alexander P; Snead K; Hartig N; Drew M; Messing S; Finci LI; Nissley DV; McCormick F; Esposito D; Rodriguez-Viciana P; Stephen AG; Simanshu DK
    Nat Struct Mol Biol; 2022 Oct; 29(10):966-977. PubMed ID: 36175670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple central giant cell granuloma of the jaws: diagnostic signposts of Noonan syndrome and RASopathy.
    Friedrich RE; Rutkowski R; Gosau M
    Oral Maxillofac Surg; 2024 Jun; 28(2):991-997. PubMed ID: 38347383
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Sigamani V; Rajasingh S; Gurusamy N; Panda A; Rajasingh J
    Curr Genomics; 2021 Dec; 22(7):526-540. PubMed ID: 35386434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair.
    Cordeddu V; Di Schiavi E; Pennacchio LA; Ma'ayan A; Sarkozy A; Fodale V; Cecchetti S; Cardinale A; Martin J; Schackwitz W; Lipzen A; Zampino G; Mazzanti L; Digilio MC; Martinelli S; Flex E; Lepri F; Bartholdi D; Kutsche K; Ferrero GB; Anichini C; Selicorni A; Rossi C; Tenconi R; Zenker M; Merlo D; Dallapiccola B; Iyengar R; Bazzicalupo P; Gelb BD; Tartaglia M
    Nat Genet; 2009 Sep; 41(9):1022-6. PubMed ID: 19684605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shoc2 controls ERK1/2-driven neural crest development by balancing components of the extracellular matrix.
    Norcross RG; Abdelmoti L; Rouchka EC; Andreeva K; Tussey O; Landestoy D; Galperin E
    Dev Biol; 2022 Dec; 492():156-171. PubMed ID: 36265687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant N-myristoylation as a prelude to autoimmune manifestations in patients with SHOC2 mutations.
    Rigante D; Leoni C; Onesimo R; Giorgio V; Trevisan V; Zampino G
    Autoimmun Rev; 2023 Nov; 22(11):103462. PubMed ID: 37793491
    [No Abstract]   [Full Text] [Related]  

  • 11. Growth curves for height in Noonan syndrome.
    Witt DR; Keena BA; Hall JG; Allanson JE
    Clin Genet; 1986 Sep; 30(3):150-3. PubMed ID: 3780030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiofaciocutaneous syndrome, a Noonan syndrome related disorder: clinical and molecular findings in 11 patients].
    Carcavilla A; García-Miñaúr S; Pérez-Aytés A; Vendrell T; Pinto I; Guillén-Navarro E; González-Meneses A; Aoki Y; Grinberg D; Ezquieta B
    Med Clin (Barc); 2015 Jan; 144(2):67-72. PubMed ID: 25194980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral giant coronary aneurysms in a 40-year-old male with Noonan syndrome caused by a KRAS germline mutation.
    Fujimoto N; Nakajima H; Sugiura E; Dohi K; Kanemitsu S; Yamada N; Aoki Y; Nakatani K; Shimpo H; Nobori T; Ito M
    Int J Cardiol; 2014 May; 173(3):e63-6. PubMed ID: 24703799
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis of Noonan syndrome and related disorders using target next generation sequencing.
    Lepri FR; Scavelli R; Digilio MC; Gnazzo M; Grotta S; Dentici ML; Pisaneschi E; Sirleto P; Capolino R; Baban A; Russo S; Franchin T; Angioni A; Dallapiccola B
    BMC Med Genet; 2014 Jan; 15():14. PubMed ID: 24451042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A lethal course of hypertrophic cardiomyopathy in Noonan syndrome due to a novel germline mutation in the KRAS gene: case study.
    Nosan G; Bertok S; Vesel S; Yntema HG; Paro-Panjan D
    Croat Med J; 2013 Dec; 54(6):574-8. PubMed ID: 24382853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tegumentary manifestations of Noonan and Noonan-related syndromes.
    Quaio CR; de Almeida TF; Brasil AS; Pereira AC; Jorge AA; Malaquias AC; Kim CA; Bertola DR
    Clinics (Sao Paulo); 2013; 68(8):1079-83. PubMed ID: 24037001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal diagnostic testing of the Noonan syndrome genes in fetuses with abnormal ultrasound findings.
    Croonen EA; Nillesen WM; Stuurman KE; Oudesluijs G; van de Laar IM; Martens L; Ockeloen C; Mathijssen IB; Schepens M; Ruiterkamp-Versteeg M; Scheffer H; Faas BH; van der Burgt I; Yntema HG
    Eur J Hum Genet; 2013 Sep; 21(9):936-42. PubMed ID: 23321623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-year growth in children with Noonan syndrome: Associated with feeding problems?
    Croonen EA; Draaisma JMT; van der Burgt I; Roeleveld N; Noordam C
    Am J Med Genet A; 2018 Apr; 176(4):951-958. PubMed ID: 29575624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Growth Hormone Therapy on Adult Height in Patients with PTPN11 Mutations Related to Noonan Syndrome.
    Malaquias AC; Noronha RM; Souza TTO; Homma TK; Funari MFA; Yamamoto GL; Silva FV; Moraes MB; Honjo RS; Kim CA; Nesi-França S; Carvalho JAR; Quedas EPS; Bertola DR; Jorge AAL
    Horm Res Paediatr; 2019; 91(4):252-261. PubMed ID: 31132774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth patterns of patients with Noonan syndrome: correlation with age and genotype.
    Cessans C; Ehlinger V; Arnaud C; Yart A; Capri Y; Barat P; Cammas B; Lacombe D; Coutant R; David A; Baron S; Weill J; Leheup B; Nicolino M; Salles JP; Verloes A; Tauber M; Cavé H; Edouard T
    Eur J Endocrinol; 2016 May; 174(5):641-50. PubMed ID: 26903553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.